Compare MREO & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MREO | RDVT |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 830.2M |
| IPO Year | N/A | N/A |
| Metric | MREO | RDVT |
|---|---|---|
| Price | $2.20 | $53.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $7.50 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 2.1M | 85.9K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | N/A | ★ 119.82 |
| EPS | N/A | ★ 0.78 |
| Revenue | $500,000.00 | ★ $86,425,000.00 |
| Revenue This Year | N/A | $20.55 |
| Revenue Next Year | $131.12 | $14.27 |
| P/E Ratio | ★ N/A | $68.61 |
| Revenue Growth | N/A | ★ 22.27 |
| 52 Week Low | $1.47 | $32.23 |
| 52 Week High | $3.90 | $64.14 |
| Indicator | MREO | RDVT |
|---|---|---|
| Relative Strength Index (RSI) | 64.57 | 48.71 |
| Support Level | $2.02 | $52.77 |
| Resistance Level | $2.37 | $57.80 |
| Average True Range (ATR) | 0.15 | 2.28 |
| MACD | 0.05 | -0.08 |
| Stochastic Oscillator | 73.81 | 28.03 |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Red Violet Inc is a software and services company. It specializes in data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.